Cargando…

Quantitative Proteomic and Network Analysis of Differentially Expressed Proteins in PBMC of Friedreich’s Ataxia (FRDA) Patients

Friedreich’s ataxia (FRDA) is an autosomal recessive neurodegenerative disorder caused by an expanded (GAA) trinucleotide repeat in the FXN gene. The extended repeats expansion results in reduced transcription and, thereby, decreased expression of the mitochondrial protein, frataxin. Given the ongoi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pathak, Deepti, Srivastava, Achal Kumar, Padma, M. V., Gulati, Sheffali, Rajeswari, Moganty R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802492/ https://www.ncbi.nlm.nih.gov/pubmed/31680804 http://dx.doi.org/10.3389/fnins.2019.01054

Ejemplares similares

Gene Expression Profiling of Mitochondrial Oxidative Phosphorylation (OXPHOS) Complex I in Friedreich Ataxia (FRDA) Patients
por: Salehi, Mohammad Hossein, et al.
Publicado: (2014)

Multiple mechanisms underpin cerebral and cerebellar white matter deficits in Friedreich ataxia: The IMAGE‐FRDA study
por: Selvadurai, Louisa P., et al.
Publicado: (2020)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Cerebrospinal Fluid Proteomics in Friedreich Ataxia Reveals Markers of Neurodegeneration and Neuroinflammation
por: Imbault, Virginie, et al.
Publicado: (2022)

Skeletal muscle proteome analysis underpins multifaceted mitochondrial dysfunction in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2023)

Plasma Markers of Neurodegeneration Are Raised in Friedreich’s Ataxia
por: Zeitlberger, Anna M., et al.
Publicado: (2018)

Erythropoietin and Friedreich Ataxia: Time for a Reappraisal?
por: Boesch, Sylvia, et al.
Publicado: (2019)

Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893)

Cerebellar Pathology in an Inducible Mouse Model of Friedreich Ataxia
por: Mercado-Ayón, Elizabeth, et al.
Publicado: (2022)

Calcium Deregulation: Novel Insights to Understand Friedreich’s Ataxia Pathophysiology
por: Abeti, Rosella, et al.
Publicado: (2018)

Epigenetic Heterogeneity in Friedreich Ataxia Underlies Variable FXN Reactivation
por: Rodden, Layne N., et al.
Publicado: (2021)

The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905)

Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022)

Progression of Friedreich ataxia: quantitative characterization over 5 years
por: Patel, Maya, et al.
Publicado: (2016)

Large Interruptions of GAA Repeat Expansion Mutations in Friedreich Ataxia Are Very Rare
por: Al-Mahdawi, Sahar, et al.
Publicado: (2018)

Sensitivity of Neuroimaging Indicators in Monitoring the Effects of Interferon Gamma Treatment in Friedreich’s Ataxia
por: Vavla, Marinela, et al.
Publicado: (2020)

Bone Mineral Density and Current Bone Health Screening Practices in Friedreich’s Ataxia
por: Dunn, Julia, et al.
Publicado: (2022)

Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)

The Pathogenesis of Cardiomyopathy in Friedreich Ataxia
por: Koeppen, Arnulf H., et al.
Publicado: (2015)

Depressive symptoms in Friedreich ataxia
por: Nieto, Antonieta, et al.
Publicado: (2018)

Heart disease in Friedreich’s ataxia
por: Hanson, Emily, et al.
Publicado: (2019)

Two Cases of Friedreich’s Ataxia
por: Stephenson, F. H.
Publicado: (1897)

Respiratory Function in Friedreich’s Ataxia
por: Vinante, Elena, et al.
Publicado: (2022)

Sequencing through hyperexpanded Friedreich’s ataxia-GAA repeats by nanopore technology: implications in genotype–phenotype correlation
por: Uppili, Bharathram, et al.
Publicado: (2023)

Nrf2 Induction Re-establishes a Proper Neuronal Differentiation Program in Friedreich’s Ataxia Neural Stem Cells
por: La Rosa, Piergiorgio, et al.
Publicado: (2019)

Mechanism of Action of 2-Aminobenzamide HDAC Inhibitors in Reversing Gene Silencing in Friedreich’s Ataxia
por: Soragni, Elisabetta, et al.
Publicado: (2015)

Friedreich ataxia in a family from Mali, West Africa/Friedreich ataxia in a Malian family
por: Cissé, Cheick A. K., et al.
Publicado: (2021)

A new FRDA mouse model [Fxn(null):YG8s(GAA) > 800] with more than 800 GAA repeats
por: Kalef-Ezra, Ester, et al.
Publicado: (2023)

Anaesthesia for a patient with Friedreich's ataxia
por: Ganesan, Ilango
Publicado: (2011)

Hepatic mitochondrial dysfunction in Friedreich Ataxia
por: Stüwe, Sven H, et al.
Publicado: (2011)

Epigenetic-based therapies for Friedreich ataxia
por: Sandi, Chiranjeevi, et al.
Publicado: (2014)

Identification of telomere dysfunction in Friedreich ataxia
por: Anjomani Virmouni, Sara, et al.
Publicado: (2015)

Otoneurological Abnormalities in Patients with Friedreich's Ataxia
por: Zeigelboim, Bianca Simone, et al.
Publicado: (2016)

The role of oxidative stress in Friedreich's ataxia
por: Lupoli, Federica, et al.
Publicado: (2017)

Two Cases of Friedreich's Ataxia in Adolescents
por: Fergus, John
Publicado: (1917)

Drosophila melanogaster Models of Friedreich's Ataxia
por: Calap-Quintana, P., et al.
Publicado: (2018)

Autonomic function testing in Friedreich’s ataxia
por: Indelicato, Elisabetta, et al.
Publicado: (2018)

An Overview of the Ferroptosis Hallmarks in Friedreich’s Ataxia
por: Turchi, Riccardo, et al.
Publicado: (2020)

Predictors of loss of ambulation in Friedreich's ataxia
por: Rummey, Christian, et al.
Publicado: (2020)

Cardiomyopathy as the first manifestation of Friedreich's ataxia
por: Maffei, Rafael Tuzino Leite Neves, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5q1nvbrnirtbs4jdpko5d9008k